CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Belgian startup revives Galapagos CAR-T research

PartnershipCAR-T cell therapiesPositive
AI Analysis

Summary

Armed Cell Therapeutics, chaired by former Galapagos CEO Paul Stoffels, has acquired CAR-T cell therapy assets that were previously divested by Lakefront Biotherapeutics (formerly Galapagos) during a strategic overhaul.

Importance:5/10
Sentiment:
0.30
CAR-Tcell therapyasset acquisitionstrategic partnershipPaul Stoffels
Related Companies

Read the original article

Published by BioPharma Dive on October 15, 2026 3:55 PM

Read Original